GeneCopoeia carries complete suites of state-of-the-art products for gene delivery using lentivirus and adenoassociated virus (AAV).
GeneCopoeia's lentiviral solutions include:
- Lentiviral plasmids. Available for expressing ORF cDNAs, gene promoters, miRNA precursors and inhibitors, CRISPR sgRNAs, and shRNAs for do-it-yourself, 3rd generation lentiviral packaging. Use the "Plasmids" tab for ordering information.
- Ready-to-use particles. For infection of most mammalian cell types with either standard VSV-G pseudotyping, or for infection of ACE2-expressing cells with SARS-CoV-2 Spike glycoprotein pseudotyping. These particles can be produced in either in vitro or in vivo grade. See the lentivirus drop down menus below for ordering information.
- Packaging kits. Enable you to package lentiviral transfer plasmids with either standard VSV-G pseudotyping or SARS-CoV-2 Spike glycoprotein pseudotyping. Use the packaging kits drop down menu below for ordering information.
GeneCopoeia's AAV solutions include:
- Ready-to-use particles. For infection of many mammalian cell types in nearly all available serotypes. These particles are be produced in in vivo grade, and can be used either in vitro or in vivo. Use the AAV drop down menu below for ordering information.
- Serotype testing kits. For determining which AAV serotype(s) are best for infecting your cells of interest.
Lentiviral particles for SARS-CoV-2 viral protein expression are available for 2 primary applications: GU280_gp08 For more information or to request a quote, please contact inquiry@genecopoeia.com. For more information or to request a quote, please contact inquiry@genecopoeia.com. To order AAV particles expressing SARS-CoV-2 viral proteins in one of out more than 250 non-viral and lentiviral vector types, select the product ID from the table below and contact inquiry@genecopoeia.com. GU280_gp08 For more information or to request a quote, please contact inquiry@genecopoeia.com. For more information or to request a quote, please contact inquiry@genecopoeia.com.
Product ID
Protein accession
Symbol
Alias
Description
NV202
YP_009725297.1
orf1ab
GU280_gp01
leader protein [Severe acute respiratory syndrome coronavirus 2], mature peptide*
NV203
YP_009725298.1
orf1ab
GU280_gp01
nsp2n [Severe acute respiratory syndrome coronavirus 2], mature peptide*
NV204
YP_009725299.1
orf1ab
GU280_gp01
nsp3n [Severe acute respiratory syndrome coronavirus 2], mature peptide*
NV205
YP_009725300.1
orf1ab
GU280_gp01
nsp4n [Severe acute respiratory syndrome coronavirus 2], mature peptide*
NV206
YP_009725301.1
orf1ab
GU280_gp01
3C-like proteinase [Severe acute respiratory syndrome coronavirus 2], mature peptide*
NV207
YP_009725302.1
orf1ab
GU280_gp01
nsp6n [Severe acute respiratory syndrome coronavirus 2], mature peptide*
NV208
YP_009725303.1
orf1ab
GU280_gp01
nsp7n [Severe acute respiratory syndrome coronavirus 2], mature peptide*
NV209
YP_009725304.1
orf1ab
GU280_gp01
nsp8n [Severe acute respiratory syndrome coronavirus 2], mature peptide*
NV210
YP_009725305.1
orf1ab
GU280_gp01
nsp9n [Severe acute respiratory syndrome coronavirus 2], mature peptide*
NV211
YP_009725306.1
orf1ab
GU280_gp01
nsp10n [Severe acute respiratory syndrome coronavirus 2], mature peptide*
NV212
YP_009725307.1
orf1ab
GU280_gp01
RNA-dependent RNA polymerase [Severe acute respiratory syndrome coronavirus 2], mature peptide*
NV213
YP_009725308.1
orf1ab
GU280_gp01
helicase [Severe acute respiratory syndrome coronavirus 2], mature peptide*
NV214
YP_009725309.1
orf1ab
GU280_gp01
3'-to-5' exonuclease [Severe acute respiratory syndrome coronavirus 2], mature peptide*
NV215
YP_009725310.1
orf1ab
GU280_gp01
endoRNAse [Severe acute respiratory syndrome coronavirus 2], mature peptide*
NV216
YP_009725311.1
orf1ab
GU280_gp01
2'-O-ribose methyltransferase [Severe acute respiratory syndrome coronavirus 2], mature peptide*
NV218
YP_009725312.1
orf1a
GU280_gp01
produced by pp1a only [Severe acute respiratory syndrome coronavirus 2], mature peptide*
NV219
YP_009724390.1
S
GU280_gp02
surface glycoprotein;structural protein; spike protein [Severe acute respiratory syndrome coronavirus 2], full-length gene (codon optimized)
NV220
YP_009724390.1
S1
GU280_gp02
surface glycoprotein subunit 1 [Severe acute respiratory syndrome coronavirus 2], mature peptide (codon optimized)
NV221
YP_009724390.1
S2
GU280_gp02
surface glycoprotein subunit 2 [Severe acute respiratory syndrome coronavirus 2], mature peptide* (codon optimized)
NV222
YP_009724390.1
RBD
GU280_gp02
Receptor binding domain [Severe acute respiratory syndrome coronavirus 2], mature peptide* (codon optimized)
NV223
YP_009724391.1
ORF3a
GU280_gp03
ORF3a protein [Severe acute respiratory syndrome coronavirus 2], full-length gene
NV224
YP_009724392.1
E
GU280_gp04
envelope protein [Severe acute respiratory syndrome coronavirus 2], full-length gene
NV225
YP_009724393.1
M
GU280_gp05
membrane glycoprotein [Severe acute respiratory syndrome coronavirus 2], full-length gene
NV226
YP_009724394.1
ORF6
GU280_gp06
ORF6 protein [Severe acute respiratory syndrome coronavirus 2], full-length gene
NV227
YP_009724395.1
ORF7a
GU280_gp07
ORF7a protein [Severe acute respiratory syndrome coronavirus 2], full-length gene
NV228
YP_009725318.1
ORF7b
ORF7b [Severe acute respiratory syndrome coronavirus 2], full-length gene
NV229
YP_009724396.1
ORF8
GU280_gp09
ORF8 protein [Severe acute respiratory syndrome coronavirus 2], full-length gene
NV230
YP_009724397.2
N
GU280_gp10
nucleocapsid phosphoprotein [Severe acute respiratory syndrome coronavirus 2], full-length gene
NV231
YP_009725255.1
ORF10
GU280_gp11
ORF10 protein [Severe acute respiratory syndrome coronavirus 2], full-length gene *Note: Mature peptides are produced as a result of proteolytic processing of larger precursor proteins. To enable expression of these proteins in cells, an ATG has been added to the 5' end of the ORF sequence.
Lentivirus particles expressing ACE2
Lentivirus particles expressing TMPRSS2
Premade lentivirus expressing human host factors needed for SARS-CoV-2 pathogenesis
Order AAV particles expressing SARS-CoV-2 viral proteins
Product ID
Protein accession
Symbol
Alias
Description
NV202
YP_009725297.1
orf1ab
GU280_gp01
leader protein [Severe acute respiratory syndrome coronavirus 2], mature peptide*
NV203
YP_009725298.1
orf1ab
GU280_gp01
nsp2n [Severe acute respiratory syndrome coronavirus 2], mature peptide*
NV205
YP_009725300.1
orf1ab
GU280_gp01
nsp4n [Severe acute respiratory syndrome coronavirus 2], mature peptide*
NV206
YP_009725301.1
orf1ab
GU280_gp01
3C-like proteinase [Severe acute respiratory syndrome coronavirus 2], mature peptide*
NV207
YP_009725302.1
orf1ab
GU280_gp01
nsp6n [Severe acute respiratory syndrome coronavirus 2], mature peptide*
NV208
YP_009725303.1
orf1ab
GU280_gp01
nsp7n [Severe acute respiratory syndrome coronavirus 2], mature peptide*
NV209
YP_009725304.1
orf1ab
GU280_gp01
nsp8n [Severe acute respiratory syndrome coronavirus 2], mature peptide*
NV210
YP_009725305.1
orf1ab
GU280_gp01
nsp9n [Severe acute respiratory syndrome coronavirus 2], mature peptide*
NV211
YP_009725306.1
orf1ab
GU280_gp01
nsp10n [Severe acute respiratory syndrome coronavirus 2], mature peptide*
NV212
YP_009725307.1
orf1ab
GU280_gp01
RNA-dependent RNA polymerase [Severe acute respiratory syndrome coronavirus 2], mature peptide*
NV213
YP_009725308.1
orf1ab
GU280_gp01
helicase [Severe acute respiratory syndrome coronavirus 2], mature peptide*
NV214
YP_009725309.1
orf1ab
GU280_gp01
3'-to-5' exonuclease [Severe acute respiratory syndrome coronavirus 2], mature peptide*
NV215
YP_009725310.1
orf1ab
GU280_gp01
endoRNAse [Severe acute respiratory syndrome coronavirus 2], mature peptide*
NV216
YP_009725311.1
orf1ab
GU280_gp01
2'-O-ribose methyltransferase [Severe acute respiratory syndrome coronavirus 2], mature peptide*
NV218
YP_009725312.1
orf1a
GU280_gp01
produced by pp1a only [Severe acute respiratory syndrome coronavirus 2], mature peptide*
NV219
YP_009724390.1
S
GU280_gp02
surface glycoprotein;structural protein; spike protein [Severe acute respiratory syndrome coronavirus 2], full-length gene (codon optimized)
NV220
YP_009724390.1
S1
GU280_gp02
surface glycoprotein subunit 1 [Severe acute respiratory syndrome coronavirus 2], mature peptide (codon optimized)
NV221
YP_009724390.1
S2
GU280_gp02
surface glycoprotein subunit 2 [Severe acute respiratory syndrome coronavirus 2], mature peptide* (codon optimized)
NV222
YP_009724390.1
RBD
GU280_gp02
Receptor binding domain [Severe acute respiratory syndrome coronavirus 2], mature peptide* (codon optimized)
NV223
YP_009724391.1
ORF3a
GU280_gp03
ORF3a protein [Severe acute respiratory syndrome coronavirus 2], full-length gene
NV224
YP_009724392.1
E
GU280_gp04
envelope protein [Severe acute respiratory syndrome coronavirus 2], full-length gene
NV225
YP_009724393.1
M
GU280_gp05
membrane glycoprotein [Severe acute respiratory syndrome coronavirus 2], full-length gene
NV226
YP_009724394.1
ORF6
GU280_gp06
ORF6 protein [Severe acute respiratory syndrome coronavirus 2], full-length gene
NV227
YP_009724395.1
ORF7a
GU280_gp07
ORF7a protein [Severe acute respiratory syndrome coronavirus 2], full-length gene
NV228
YP_009725318.1
ORF7b
ORF7b [Severe acute respiratory syndrome coronavirus 2], full-length gene
NV229
YP_009724396.1
ORF8
GU280_gp09
ORF8 protein [Severe acute respiratory syndrome coronavirus 2], full-length gene
NV230
YP_009724397.2
N
GU280_gp10
nucleocapsid phosphoprotein [Severe acute respiratory syndrome coronavirus 2], full-length gene
NV231
YP_009725255.1
ORF10
GU280_gp11
ORF10 protein [Severe acute respiratory syndrome coronavirus 2], full-length gene *Note: Mature peptides are produced as a result of proteolytic processing of larger precursor proteins. To enable expression of these proteins in cells, an ATG has been added to the 5' end of the ORF sequence.
Custom AAV expressing ACE2
Custom AAV expressing TMPRSS2
Webinars
Title: Advanced Tools For COVID-19 Coronavirus Research From GeneCopoeia
Presented Wednesday, September 9, 2020
The COVID-19 global pandemic, caused by the SARS-CoV-2 coronavirus, highlights an urgent need for diagnostic reagents, antiviral therapeutics, and vaccine development. In this webinar, we will discuss GeneCopoeia's advanced solutions including testing kits, SARS-CoV-2 pseudotyped virus, and other tools needed for research into combating this deadly disease.